{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:06:42Z","timestamp":1793383602449,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Despite advances in antiemetics and protocolized postoperative nausea vomiting (PONV) management, it remains one of the most common postoperative adverse events. In patients who developed PONV despite antiemetic prophylaxis, giving a rescue treatment from the same class of medication is known to be of limited efficacy. Given the widespread use of 5-HT3 antagonists as PONV prophylaxis, another class of effective intravenous rescue antiemetic is in dire need, especially when prophylaxis fails, and rescue medication is utilized. Dopamine antagonists were widely used for the treatment of PONV but have fallen out of favor due to some of their side effect profiles. Amisulpride was first designed as an antipsychotic medication but was found to have antiemetic properties. Here we will review the historical perspective on the use of dopamine receptor antagonist antiemetics, as well as the evidence on the efficacy and safety of amisulpride.<\/jats:p>","DOI":"10.3389\/fphar.2023.1274214","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:55:19Z","timestamp":1698749719000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Perioperative utility of amisulpride and dopamine receptor antagonist antiemetics-a narrative review"],"prefix":"10.3389","volume":"14","author":[{"given":"Murad","family":"Elias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Gombert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaimaan","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaosheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Bergese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1097\/00000542-200412000-00028","article-title":"Is low-dose haloperidol a useful antiemetic?","volume":"101","author":"B\u00fcttner","year":"2004","journal-title":"Anesthesiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1213\/ANE.0000000000003733","article-title":"Randomized, double-blind, placebo-controlled study of intravenous amisulpride as treatment of established postoperative nausea and vomiting in patients who have had No prior prophylaxis","volume":"128","author":"Candiotti","year":"2019","journal-title":"Anesth. Analg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"748031","DOI":"10.1155\/2011\/748031","article-title":"Current concepts in the management of postoperative nausea and vomiting","volume":"2011","author":"Chatterjee","year":"2011","journal-title":"Anesthesiol. Res. Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ajem.2022.01.011","article-title":"Emergency medicine updates: droperidol","volume":"53","author":"Cisewski","year":"2022","journal-title":"Am. J. Emerg. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000503382","article-title":"Is low-dose haloperidol effective against postoperative nausea and vomiting? A randomized controlled trial","volume":"2","author":"Da\u011f","year":"2019","journal-title":"Dubai Med. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"bcr2013010133","DOI":"10.1136\/bcr-2013-010133","article-title":"Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting?","volume":"2013","author":"Dixit","year":"2013","journal-title":"BMJ Case Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/00000539-199906000-00032","article-title":"Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis","volume":"88","author":"Domino","year":"1999","journal-title":"Anesth. Analgesia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1046\/j.1365-2044.2002.02822.x","article-title":"Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting","volume":"57","author":"Eberhart","year":"2002","journal-title":"Anaesthesia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/00000539-199804000-00011","article-title":"A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups","volume":"86","author":"Fortney","year":"1998","journal-title":"Anesth. Analgesia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1213\/ANE.0000000000004538","article-title":"Intravenous amisulpride does not meaningfully prolong the QTc interval at doses effective for the management of postoperative nausea and vomiting","volume":"132","author":"Fox","year":"2021","journal-title":"Anesth. Analg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","article-title":"Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (published correction appears in Anesth Analg. 2020 Nov;131(5):e241)","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth. Analg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1213\/ANE.0000000000006126","article-title":"Rescue treatment of postoperative nausea and vomiting: a systematic review of current clinical evidence","volume":"135","author":"Gan","year":"2022","journal-title":"Anesth. Analg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/ALN.0000000000001458","article-title":"Intravenous amisulpride for the prevention of postoperative nausea and vomiting: two concurrent, randomized, double-blind, placebo-controlled trials","volume":"126","author":"Gan","year":"2017","journal-title":"Anesthesiology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/JCP.0b013e318166c4d5","article-title":"Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review","volume":"28","author":"Gao","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.bpa.2020.07.003","article-title":"Clinical and economic burden of postoperative nausea and vomiting: analysis of existing cost data","volume":"34","author":"Gress","year":"2020","journal-title":"Best. Pract. Res. Clin. Anaesthesiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1185\/030079906X104830","article-title":"Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis","volume":"22","author":"Habib","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1213\/01.ANE.0000063923.87560.37","article-title":"Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases","volume":"96","author":"Habib","year":"2003","journal-title":"Anesth. Analgesia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/ALN.0000000000002509","article-title":"Amisulpride for the rescue treatment of postoperative nausea or vomiting in patients failing prophylaxis: a randomized, placebo-controlled phase III trial","volume":"130","author":"Habib","year":"2019","journal-title":"Anesthesiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"CD003443","DOI":"10.1002\/14651858.CD003443.pub3","article-title":"Perphenazine for schizophrenia","volume":"2015","author":"Hartung","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/bja\/83.5.761","article-title":"Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies","volume":"83","author":"Henzi","year":"1999","journal-title":"Br. J. Anaesth."},{"key":"B21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/00000542-200004000-00012","article-title":"Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo","volume":"92","author":"Hill","year":"2000","journal-title":"Anesthesiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejphar.2013.10.037","article-title":"Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting","volume":"722","author":"Horn","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/clpt.2011.107","article-title":"Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses","volume":"90","author":"Joy","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/ALN.0000000000002133","article-title":"Amisulpride prevents postoperative nausea and vomiting in patients at high risk: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Kranke","year":"2018","journal-title":"Anesthesiology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/bja\/aet251","article-title":"I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial","volume":"111","author":"Kranke","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"B26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2165\/00003088-199937060-00001","article-title":"Pharmacokinetics of haloperidol: an update","volume":"37","author":"Kudo","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.5114\/aoms.2015.50968","article-title":"Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting","volume":"11","author":"Matsota","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2165\/00003495-200666160-00009","article-title":"Intravenous droperidol: a review of its use in the management of postoperative nausea and vomiting","volume":"66","author":"McKeage","year":"2006","journal-title":"J. Intraven. Droperidol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.0065-1591.2000.007s021(dash)5.x","article-title":"Safety profile of amisulpride in short- and long-term use","volume":"400","author":"Rein","year":"2000","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hup.320","article-title":"A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers","volume":"17","author":"Rosenzweig","year":"2002","journal-title":"Hum. Psychopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1389200033489523","article-title":"Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view","volume":"4","author":"Sharma","year":"2003","journal-title":"Curr. Drug Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0002-9149(97)00888-6","article-title":"Torsades de Pointes associated with intravenous haloperidol in critically ill patients","volume":"81","author":"Sharma","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/AOG.0b013e3181d99290","article-title":"Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial","volume":"115","author":"Tan","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"CD012859","DOI":"10.1002\/14651858.CD012859.pub2","article-title":"Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis","volume":"10","author":"Weibel","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/00000539-200210000-00001","article-title":"Droperidol: a cost-effective antiemetic for over thirty years","volume":"95","author":"White","year":"2002","journal-title":"Anesth. Analgesia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00228-020-02869-1","article-title":"Efficacy of amisulpride on postoperative nausea and vomiting: a systematic review and meta-analysis","volume":"76","author":"Zhang","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1274214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:55:21Z","timestamp":1698749721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1274214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":36,"alternative-id":["10.3389\/fphar.2023.1274214"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1274214","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"article-number":"1274214"}}